-
Views
-
Cite
Cite
Mei Wang, Christopher E. Price, Jenny Han, Jason Cisler, Kiyoshi Imaizumi, Marie Neëlle Van Thienen, Anne Depaepe, Maurice Godfrey, Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome, Human Molecular Genetics, Volume 4, Issue 4, April 1995, Pages 607–613, https://doi.org/10.1093/hmg/4.4.607
- Share Icon Share
Abstract
The Marfan syndrome (MFS) is an autosomal domainant heritable disorder of connective tissue. Variable and plelotropic clinical features are observed in the skeletal, ocular, and cardiovascular systems. The most severe end of the phenotypic spectrum of this disorder comprises a group of patients usually diagnosed at birth, who have a life expectancy of little more than a year, To distinguish this group of patients from those with classical MFS, we refer to them as neonatal Marfan syndrome (nMFS). These infants usually die of congestive heart failure rather than aortic aneurysmal disease, the most frequent cause of morbidity and mortality in classical MFS. Defects in fibrillin, an elastin-associated microfibrillar glycoprotein, are now known to cause both the classical and neonatal forms of MFS. Here we report the recurrent mis-splicing of fibrillin (FBN1) exon 32, a precursor EGF-like calcium binding domain, in two unrelated infants with nMFS. The mis-splicing, in one patient, was dur to an A→T transversion at the −2 position of the consensus acceptor splice site; while that in the second patient was caused by a G→A transition at the + position of the donor splice site. Characterization ofFBN1 mutations in individuals at the most severe end of the Marfan syndrome spectrum should provide greater understanding of the multiple domains and regions of fibrillin.